Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06536296 · ClinicalTrials.gov registry record · NA
The Impact of Music Medicine on Preterm Brain Development and Behavior
A NA study of Stress and Infant Development, sponsored by Brigham and Women's Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 243
- Enrollment target
- 2
- Study locations
NCT06536296: Recruiting NA study of Stress and Infant Development, sponsored by Brigham and Women's Hospital.
NCT06536296 is a NA study of Stress and Infant Development that is actively recruiting participants, run by Brigham and Women's Hospital. The registered enrollment target is 243 participants, below the 785-participant average among 152 other Stress trials with a reported enrollment target (69% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06536296, a NA study of Stress and Infant Development, is actively recruiting participants, sponsored by Brigham and Women's Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 243 participants
- Enrollment target
- 2
- Study locations
Study Summary
The investigators are conducting a two-site randomized control trial with the aim of defining the impact of music (M) without or with parent voice (MPV) on very preterm infants' acute and cumulative stress, intranetwork connectivity on term brain MRI, and language and other neurodevelopmental outcomes at two years corrected age. This is based on the hypothesis that infants in MPV arm are expected to experience the greatest benefit compared with infants receiving standard care.
Primary Outcome
Study patients Language performance measured on the Bayley-4 at 2 years corrected age
Conditions Studied
Interventions
- OTHER Standard Care
- OTHER Music
- OTHER Music and parent voice
Study Locations (2)
Connecticut
- Yale New Haven Hospital - New Haven
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 243 participants |
| Start Date | 2025-05-19 |
| Est. Completion | 2031-03-01 |
| Phase | NA |
What NCT06536296 shows while recruiting
NCT06536296 is an interventional study that assigns participants to a tested intervention. The registered 243 participants enrollment target is mid-sized for trials with a published cap, below the 785-participant average among 152 other Stress trials with a reported enrollment target (69% lower).
The record links to 4 conditions, with Stress appearing as the primary indexed condition, and to 3 interventions - of which Standard Care is the first listed.
NCT06536296 reports a single indexed study location in Connecticut, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06536296 about?
NCT06536296 is a clinical study titled "The Impact of Music Medicine on Preterm Brain Development and Behavior". The investigators are conducting a two-site randomized control trial with the aim of defining the impact of music (M) without or with parent voice (MPV) on very preterm infants' acute and cumulative stress, intranetwork connectivity on term brain MRI, and language and other neurodevelopmental outcom...
What is the current status of trial NCT06536296?
This trial is currently recruiting. It is a NA study. The enrollment target is 243 participants. The study started on 2025-05-19. Estimated completion is 2031-03-01.
What conditions does trial NCT06536296 study?
This clinical trial studies the following conditions: Stress, Infant Development, Prematurity, Language Development.
What interventions are being tested in trial NCT06536296?
The interventions under investigation include: Standard Care (OTHER), Music (OTHER), Music and parent voice (OTHER).
Who is sponsoring clinical trial NCT06536296?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06536296 being conducted?
This trial has 2 study locations across Connecticut, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stress
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06536296's enrollment target sits among peer trials
243 25th of 152 higher than 128 of 152 other Stress trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stress trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mindfulness-Based Intervention With a Supplement for Stress-Related Problems in College Students Across Multiple Sites (4SITE)
RECRUITING · NA
-
Digital Intervention for Physical Activity
RECRUITING · NA
-
Cocooned Moms Study
RECRUITING · NA
-
Student Exercise and Sleep Timing Study - Part 2
RECRUITING · NA
-
Smartphone-based Cognitive Emotion Regulation Training for Unpaid Primary Caregivers of Persons With Alzheimer's Disease
RECRUITING · NA
-
ACT for HIV-Positive Men
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06253871 · 243 participants · Phase 1
A Phase 1/1b Study of IAM1363 in HER2 Cancers
- NCT06289491 · 243 participants · NA
A Trial of Hydrus Microstent Versus Goniotomy
- NCT06907615 · 243 participants · Phase 2
A Phase II Clinical Study to Evaluate HLX43 in Subjects With Advanced Non-small Cell Lung Cancer (NSCLC)
- NCT02227251 · 244 participants · Phase 2
Selinexor (KPT-330) in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI